Biogenesis of mitochondria: XLI. Physical mapping of mitochondrial genetic markers in yeast

This paper describes the physical mapping of five antibiotic resistance markers on the mitochondrial genome of Saccharomyces cerevisiae. The physical separations between markers were derived from studies involving a series of stable spontaneous petite strains which were isolated and characterized for the loss or retention of combinations of the five resistance markers. DNA-DNA hybridization using ³²P-labelled grande mitochondrial DNA was employed to determine the fraction of grande mitochondrial DNA sequences retained by each of the defined petite strains.One petite clone retaining four of the markers in a segment comprising 36% of the grande genome was then chosen as a reference petite. The sequence homology between the mitochondrial DNA of this petite and that of the other petites was measured by DNA-DNA hybridization. For each petite, the total length of its genome derived by hybridization with grande mitochondrial DNA and the fraction of the grande genome retained in common with the reference petite, together with the genetic markers retained in common, were used to position the DNA segment of each petite relative to the reference petite genome. At the same time the relative physical location of the five markers on a circular genome was established. On the basis of the grande mitochondrial genome being defined as 100 units of DNA, the positions of the markers were determined to bo as follows, measuring from one end of the reference petite genome. chloramphenicol (cap1) ~ 0 units erythromycin (ery1) 0 to 15 units oligomycin (oli1) 18 to 19 units mikamycin (mik1) 22 to 25 units paromomycin (par1) 61 to 73 unitsThe general problems of mapping mitochondrial genetic markers by hybridizations involving petite mitochondrial DNA are discussed. Two very important features of petite genomes which could invalidate the interpretation of DNA-DNA hybridization experiments between petite mitochondrial DNAs are the possible presence in the reference petite of differentially amplified DNA sequences, and/or “new” sequences which are not present in the parent grande genome. A general procedure, which overcomes errors of interpretation arising from these two features is described.